Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Adjuvant Pemetrexed and Oxaliplatin in Resected NSCLC
NCT00923637Phase 2Unknown
- Sponsor
- The First Affiliated Hospital of Guangzhou Medical University
- Start
- Jun 2009
- Primary completion
- Jun 2014
- Modality
- DNA Intercalators/Alkylators
- Countries
- 1
01
Overview
A Phase 2 trial of pemetrexed, oxaliplatin in non-small cell lung cancer (NSCLC), sponsored by The First Affiliated Hospital of Guangzhou Medical University. Status: unknown.
02
Drugs
pemetrexedoxaliplatin
03
Conditions
non-small cell lung cancer (NSCLC)
Beyond the preview
Go deeper on NCT00923637.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00923637.